Sudden cardiac death in long-term follow-up in patients treated with primary percutaneous coronary intervention

References

• Docherty KF, Ferreira JP, Sharma A, et al. Predictors of sudden cardiac death in high-risk patients following a myocardial infarction. Eur J Heart Fail. 2020;22(5):848–855.
   PubMed Web of Science ®Google Scholar
• Hui SK, Sharma A, Docherty K, et al. Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-risk myocardial infarction database. Eur Heart J Acute Cardiovasc Care. 2021;10(2):127–131.
   PubMed Web of Science ®Google Scholar
• Shiga T, Hagiwara N, Ogawa H, Heart Institute of Japan Acute Myocardial Infarction-II (HIJAMI-II) Investigators, et al. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry. Heart. 2009;95(3):216–220.
   PubMed Web of Science ®Google Scholar
• Hall TS, von Lueder TG, Zannad F, High-Risk Myocardial Infarction Database Initiative investigators, et al. Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction. Int J Cardiol. 2018;272:260–266.
   PubMed Web of Science ®Google Scholar
• Fan X, Hua W, Xu Y, et al. Incidence and predictors of sudden cardiac death in patients with reduced left ventricular ejection fraction after myocardial infarction in an era of revascularisation. Heart. 2014;100(16):1242–1249.
   PubMed Web of Science ®Google Scholar
• Saito K, Kondo Y, Takahashi M, et al. Factors that predict ventricular arrhythmias in the late phase after acute myocardial infarction. ESC Heart Fail. 2021;8(5):4152–4160.
   PubMed Web of Science ®Google Scholar
• Oikawa J, Fukaya H, Ako J, on behalf the J-MINUET Investigators, et al. Risk factors of in-Hospital lethal arrhythmia following acute myocardial infarction in patients undergoing primary percutaneous coronary Intervention　- Insight from the J-MINUET study. Circ Rep. 2019;2(1):17–23.
   PubMedGoogle Scholar
• Adabag S, Zimmerman P, Lexcen D, et al. Predictors of sudden cardiac arrest among patients with Post-Myocardial infarction ejection fraction greater than 35. J Am Heart Assoc. 2021;10(14):e020993.
   PubMed Web of Science ®Google Scholar
• Priori SG, Blomström-Lundqvist C, Mazzanti A, ESC Scientific Document Group, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the european society of cardiology (ESC). endorsed by: association for european paediatric and congenital cardiology (AEPC). Eur Heart J. 2015;36:2793–2867.
   PubMed Web of Science ®Google Scholar
• McDonagh TA, Metra M, Adamo M, ESC Scientific Document Group, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726.
   PubMed Web of Science ®Google Scholar
• Dagres N, Hindricks G. Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death? Eur Heart J. 2013;34(26):1964–1971.
   PubMed Web of Science ®Google Scholar
• Coiro S, Girerd N, Sharma A, et al. Association of diabetes and kidney function according to age and systolic function with the incidence of sudden cardiac death and non-sudden cardiac death in myocardial infarction survivors with heart failure. Eur J Heart Fail. 2019;21(10):1248–1258.
   PubMed Web of Science ®Google Scholar
• Deo R, Vittinghoff E, Lin F, et al. Risk factor and prediction modeling for sudden cardiac death in women with coronary artery disease. Arch Intern Med. 2011;171(19):1703–1709.
   PubMedGoogle Scholar
• Mrdovic I, Savic L, Lasica R, et al. Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the clinical center of serbia STEMI register. Eur Heart J Acute Cardiovasc Care. 2014;3(1):56–66.
   PubMedGoogle Scholar
• Doost Hosseiny A, Moloi S, Chandrasekhar J, et al. Mortality pattern and cause of death in a long-term follow-up of patients with STEMI treated with primary PCI. Open Heart. 2016;3(1):e000405.
   PubMed Web of Science ®Google Scholar
• Exner DV, Kavanagh KM, Slawnych MP, REFINE Investigators, et al. Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol. 2007;50(24):2275–2284.
   PubMed Web of Science ®Google Scholar
• Gehi A, Haas D, Fuster V. Primary prophylaxis with the implantable cardioverter-defibrillator: the need for improved risk stratification. JAMA. 2005;294(8):958–960.
   PubMed Web of Science ®Google Scholar
• Kondo Y, Noda T, Sato Y, et al. Comparison of 2-year outcomes between primary and secondary prophylactic use of defibrillators in patients with coronary artery disease: a prospective propensity score-matched analysis from the nippon storm study. Heart Rhythm O2. 2021;2(1):5–11.
   PubMedGoogle Scholar
• Ottervanger JP, Ramdat Misier AR, Dambrink JH, et al. Zwolle myocardial infarction study group. Mortality in patients with left ventricular ejection fraction ≤30% after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Am J Cardiol. 2007;100(5):793–797.
   PubMed Web of Science ®Google Scholar
• Wójcicki K, Krycińska R, Tokarek T, et al. Knowledge and prevalence of risk factors for coronary artery disease in patients after the first and repeated percutaneous coronary intervention. Kardiol Pol. 2020;78(2):147–153.
   PubMed Web of Science ®Google Scholar
• Kowalewska E, Komnacka K, Wójcicki K, et al. Sources of patients’ knowledge about cardiovascular disease prevention in Poland - a pilot study. Postepy Kardiol Interwencyjnej. 2022;18(1):27–33.
   PubMed Web of Science ®Google Scholar
• Søholm H, Lønborg J, Andersen MJ, et al. Repeated echocardiography after first ever ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention–is it necessary? Eur Heart J Acute Cardiovasc Care. 2015;4(6):528–536.
   PubMedGoogle Scholar
• Gatzoulis KA, Tsiachris D, Arsenos P, et al. Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study. Eur Heart J. 2019;40(35):2940–2949.
   PubMed Web of Science ®Google Scholar
• Tokarek T, Dziewierz A, Plens K, et al. Radial approach expertise and clinical outcomes of percutanous coronary interventions performed using femoral approach. JCM. 2019;8(9):1484.
   Google Scholar